Seven European countries, including Denmark, Norway, Austria, have temporarily halted AstraZeneca’s COVID-19 vaccine, and have begun an investigation into the case, following complaints of blood clots among those involved in dosing. Danish health officials on Tuesday postponed all of AstraZeneca’s vaccinations for two weeks. This decision was taken after a blood clot was formed in a 60-year-old woman who got dosed. Health officials said in the statement, “Many people were vaccinated with AstraZeneca’s COVID-19 vaccine. The move was taken after serious blood clot cases were reported.
However, it was also stated that it is currently not possible to conclude a connection between the vaccine and the blood clot. “The Health Agency did not provide information about Denmark’s blood clot victims. Norway also released AstraZeneca’s vaccine on Tuesday following a Danish initiative. A Norwegian official told the news conference that this is a precautionary decision. Austria also informed to stop using AstraZeneca’s vaccine after the death of a 49-year-old nurse.
She had a ‘severe blood coagulation problem’ several days after taking the Kovid-19 vaccine. The drug manufacturer AstraZeneca said in a written reply to Reuters News Agency on Thursday that the vaccine’s effect was tested through human trials. He also said that he had to undergo strict and rigorous quality control and that ‘no serious adverse effects related to the vaccine were reported’.
Apart from this, he also promised to cooperate fully with the authorities in the investigation of Austria. The European Union’s drug regulator and the European Medicines Agency said on Wednesday that no evidence has yet been found regarding the two cases involving AstraZeneca in Austria. Four other European countries, Estonia, Latvia, Lithuania and Luxembourg, have also suspended the use of AstraZeneca’s COVID-19 vaccine.
Spain on Thursday said that the blood clot complaint related to AstraZeneca’s Kovid-19 vaccine has not yet been filed and said that the vaccination will continue. On Wednesday, preliminary investigations by the European Medicines Agency denied the incident involving the use of AstraZeneca vaccine in Austria.
Preliminary view from EMA’s safety committee (#PRAC): there is no specific issue with a batch of # COVID19 Vaccine AstraZeneca that has been suspended in Austria after cases of multiple thrombosis were reported.
???? https: //t.co/292s0fSNJs pic.twitter.com/lh3BXG4e1m
– EU Medicines Agency (@EMA_News) March 10, 2021
About Oxford-AstraZeneca’s COVID-19 vaccine
The Kovid-19 vaccine from Oxford-AstraZeneca is preparing the Serum Institute of India locally in India. According to reports, the overall effect of the AstraZeneca-Oxford vaccine was 70.42 percent. A person needs to take two doses of the AstraZeneca vaccine to gain immunity.
This vegetable will be useful in softening torn ankles, this home recipe is very effective
Due to this home remedy, Rekha’s blacks are black even at the age of 66, know